Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / Common stock, $0.001 par value per share
-
Shares outstanding
-
12,986,368
-
Total 13F shares
-
11,782,213
-
Share change
-
+235,995
-
Total reported value
-
$334,227,635
-
Put/Call ratio
-
47%
-
Price per share
-
$28.37
-
Number of holders
-
152
-
Value change
-
+$6,361,041
-
Number of buys
-
72
-
Number of sells
-
80
Institutional Holders of EAGLE PHARMACEUTICALS, INC. - Common stock, $0.001 par value per share (EGRX) as of Q1 2023
As of 31 Mar 2023,
EAGLE PHARMACEUTICALS, INC. - Common stock, $0.001 par value per share (EGRX) was held by
152 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
11,782,213 shares.
The largest 10 holders included
BlackRock Inc., JANUS HENDERSON GROUP PLC, VANGUARD GROUP INC, BRANDES INVESTMENT PARTNERS, LP, DIMENSIONAL FUND ADVISORS LP, STATE STREET CORP, ADAGE CAPITAL PARTNERS GP, L.L.C., BANK OF AMERICA CORP /DE/, MILLENNIUM MANAGEMENT LLC, and AQR CAPITAL MANAGEMENT LLC.
This page lists
152
institutional shareholders reporting positions in this security
for the Q1 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.